MedTechIQ_3Helix InSight Engine-Beta
Preview
Open in TheBrain
Triple Helix Discovery Engine
"Triple Helix" Innovation Model
4. Triple Helix _ Capture Strategies
Triple Helix Open Innovation
Triple Helix: Regional Innovation Clusters (RIC)s
Intermediaries: Triple Helix Regional Innovation Clusters (RIC)s
RICS (Regional Innovation Clusters) - Medical, Life Sciences & Emerging Technology Hotspots
*Industry: Ireland
GlaxoSmithKline plc (GSK)
Organization & Developments: GSK (GlaxoSmithKline)
Parents
GlaxoSmithKline plc (GSK)
Children
*GlaxoSmithKline-GSK Center of Excellence for External Drug Discovery
*GlaxoSmithKline: Brands
*Lupus drug Benlysta from Human Genome Sciences forecasted to be potential 2011 blockbsuter
*Starting final testing for a lupus treatment
$275m=Pandemic Flu Vaccine Contract (FY 2006)
2015: 100,000 Genomes Project taps Big Pharma dream team for data crunching skills
2015: Glaxo's Connelly bows out amid scramble to turn around U.S. business
2015: GSK Selects Montgomery County for its US Global Vaccines Center
2015: GSK ventures into connected inhaler space with Propeller Health deal
2016: GlaxoSmithKline, Sanford Burnham launch neuroscience hub
2016: GlaxoSmithKline: Not All Is Good But All Is For The Good - GlaxoSmithKline (NYSE:GSK)
2016: GSK and Alphabet's Verily create $715M joint venture in bioelectronics
2017: BARDA_GSK_R&D of TRPV4 Blockade as a Novel Medical Countermeasure for Acute Respiratory Distress Syndrome due to Chlorine Gas Inihilation
2017: GlaxoSmithKline Lands Big Win For Shingles Vaccine - GlaxoSmithKline (NYSE:GSK)
2017: GlaxoSmithKline stops development of 30 pipeline prospects, mulls sale of rare disease unit as new CEO Walmsley makes her mark
2018: VA_65--GlaxoSmithKline Consumer Healthcare, LP (65IB) 65IB Drugs, Pharmaceuticals and Hematology related products
2019: BARDA_New Delivery Order to Manufacture AS03 Adjuvant System for Defense Health Agency
2020: GlaxoSmithKline: 'Future Ready' For Genomic Medicine
2021: GSK and CureVac Take Aim at COVID-19 Variants with Second-Generation mRNA Vaccine
2022: GSK severs Immatics partnership in T-cell retreat that claimed Lyell last month
2022: GSK: Why I'm Picking Up This Undervalued Gem_ seekingalpha.com
2023: A Biopharma Giant On Sale (NYSE:GSK)
2023: Arexvy Puts GSK Back On The Growth Prescription (Rating Upgrade)_seekingalpha.com
2023: As deadly pathogen spreads, GSK throws a lifeline to Scynexis with $90M deal to market antifungal
2023: GSK RSV shot approved by FDA, starting next blockbuster vaccine race
2023: What To Expect From GSK In 2023_ seekingalpha.com
2024 GSK: Robust Earnings Report Expected, 2024 Outlook Is Key
2024: ASPR takes next steps to prepare vaccine against H5 influenza ... ASPR provides approximately $72 million to CSL Seqirus, Sanofi, and GSK to boost U.S. preparedness
2024: BARDA doles out $72M to Sanofi, GSK and CSL for bird flu vaccine supply
2024: GSK aims to extend lupus dominance via $300M upfront deal for clinical-stage T-cell engager
2024: GSK Is Doing The Right Things But Can't Catch A Break - Rating Downgrade_ seekingalpha.com
2024: GSK plc 2023 Q4 - Results - Earnings Call Presentation
2024: GSK Quits Trade Group BIO as Industry Faces Uncertain Political Future
2024: GSK scratches itch for phase 3 win, hitting goal in liver disease trial to open up untapped market
2024: GSK taps a startup for shot at Alzheimer’s drug
2024: GSK: Earnings Confirm It's On Track To Meet Guidance
2024: GSK: The Worst Is Finally Over (Rating Upgrade)
2024: GSK's Q2 Success Amid Challenges: What Investors Need To Know
2024: GSK’s ViiV to expand supply of HIV drug in Africa
2024: New GSK malaria vaccine, Mosquirix, is rolled out in Africa
2025: 5 FDA decisions to watch in the first quarter of 2025
2025: GSK pays $1.2B upfront for Boston Pharmaceuticals' lead liver disease drug
2025: GSK Reported Strong Earnings, So I Reiterate My Strong Buy
2025: GSK's Strong Performance: Why I'm Upgrading To 'Strong Buy'_ seekingalpha.com
2026: GSK’s hepatitis B drug cures one-fifth of patients in ‘major step’ for pervasive disease
5 Moore Drive
GSK Ventures
Organization & Developments: GSK (GlaxoSmithKline)_Archive 2011-2014
Jumps
*Key People: GlaxoSmithKline (GSK)
Finance & Acquisitions: GlaxoSmithKline (GSK)